YM-264 is a potent and selective, orally active platelet-activating factor (PAF) antagonist used to inhibit PAF-induced platelet aggregation in human, rabbit, and guinea pig; it also suppresses antigen-induced airway hyperresponsiveness and eosinophil infiltration in vivo.